Together, these data support the hypothesis that DNA2 inhibition plays a role in promoting MM cells’ survival in the context of DNA damage activation-induced metabolic reprogramming, such as that induced by ILF2 depletion. This evidence concerns the gene DNA2 and Miyoshi myopathy.